Selected article for: "monophosphate form and triphosphate form"
Author: Van Rompay, An R; Johansson, Magnus; Karlsson, Anna
Title: Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases
  • Cord-id: 4zphlpks
  • Document date: 2003_11_4
    • ID: 4zphlpks
    Snippet: Structural analogues of nucleosides, nucleoside analogues (NA), are used in the treatment of cancer and viral infections. Antiviral NAs inhibit replication of the viral genome, whereas anticancer NAs inhibit cellular DNA replication and repair. NAs are inactive prodrugs that are dependent on intracellular phosphorylation to their pharmacologically active triphosphate form. The deoxyribonucleoside kinases (dNK) and ribonucleoside kinases (rNK) catalyze the first phosphorylation step, converting d
    Document: Structural analogues of nucleosides, nucleoside analogues (NA), are used in the treatment of cancer and viral infections. Antiviral NAs inhibit replication of the viral genome, whereas anticancer NAs inhibit cellular DNA replication and repair. NAs are inactive prodrugs that are dependent on intracellular phosphorylation to their pharmacologically active triphosphate form. The deoxyribonucleoside kinases (dNK) and ribonucleoside kinases (rNK) catalyze the first phosphorylation step, converting deoxyribonucleosides and ribonucleosides to their corresponding monophosphate form. The dNKs have been studied intensively, whereas the rNKs have not been as thoroughly investigated. This overview is focused on the substrate specificity, tissue distribution, and subcellular location of the mammalian dNKs and rNKs and their role in the activation of NAs.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and lopinavir amprenavir: 1, 2
    • acute respiratory syndrome and lopinavir amprenavir nelfinavir: 1
    • acute respiratory syndrome and lopinavir amprenavir nelfinavir indinavir: 1
    • acute respiratory syndrome and lopinavir amprenavir nelfinavir indinavir ritonavir: 1
    • acute respiratory syndrome and lopinavir amprenavir nelfinavir indinavir ritonavir saquinavir: 1
    • acute respiratory syndrome and low affinity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute respiratory syndrome and low concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52
    • acute respiratory syndrome and low frequency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute respiratory syndrome and lung brain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
    • acute respiratory syndrome and lung brain pancreas: 1, 2, 3
    • acute respiratory syndrome and lung brain pancreas heart: 1, 2, 3
    • acute respiratory syndrome and lung brain pancreas heart kidney: 1, 2
    • acute respiratory syndrome and lymphoblastic leukemia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory syndrome and lymphoblastic myeloid: 1
    • acute respiratory syndrome and lymphoblastic myeloid leukemia: 1
    • acute respiratory syndrome and lymphocytic leukemia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory syndrome and lymphoid liver: 1, 2
    • acute respiratory syndrome and lymphoid tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory syndrome and lymphoproliferative disorder: 1